Phase II study of trifluridine/tipiracil (TAS‑102) therapy in elderly patients with colorectal cancer (T‑CORE1401): geriatric assessment tools and plasma drug concentrations as possible predictive biomarkers
- Publication date
- 1 January 2021
- Publisher
- 'Springer Science and Business Media LLC'